Physicochemical Properties
| Molecular Formula | C11H11NCL2 |
| Molecular Weight | 228.11774 |
| Exact Mass | 227.027 |
| CAS # | 66504-40-3 |
| Related CAS # | Amitifadine hydrochloride;410074-74-7;DOV-216,303;86215-36-3 |
| PubChem CID | 9795276 |
| Appearance | Colorless to light yellow ointment |
| LogP | 3.183 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 14 |
| Complexity | 245 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C1=CC(=C(C=C1C23CC3CNC2)Cl)Cl |
| InChi Key | BSMNRYCSBFHEMQ-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2 |
| Chemical Name | 1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vivo | In OBX and Sham animals, acute administration of DOV-216,303 (20 mg/kg, i.p.) dramatically raises dopamine, norepinephrine, and serotonin levels [2]. In the medial prefrontal cortex of OBX and Sham mice, chronic administration of DOV 216,303 (20 mg/kg, i.p., for 17 days) raises extracellular concentrations of dopamine, norepinephrine, and serotonin and significantly increases extracellular baseline serum concentration [2]. |
| Animal Protocol |
Animal/Disease Models: Male Sprague Dawley rats weighing 290 to 350 grams at the time of OBX or sham surgery [2]. Doses: 20 mg/kg. Management: IP one time/day for 17 days. Experimental Results: Extracellular concentrations of dopamine, norepinephrine, and serotonin were increased in the medial prefrontal cortex of OBX and Sham animals, and extracellular baseline serotonin concentrations were Dramatically increased. Animal/Disease Models: Male Sprague Dawley rats weighing 290 to 350 grams at the time of OBX or sham surgery [2]. Doses: 20 mg/kg. Management: IP once. Experimental Results: Dopamine, norepinephrine, and serotonin levels were Dramatically increased in OBX and Sham animals. |
| References |
[1]. Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1438-41. [2]. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats. Eur J Pharmacol. 2010 May 10;633(1-3):55-61. |
Solubility Data
| Solubility (In Vitro) |
DMSO : ≥ 125 mg/mL (~547.96 mM) Ethanol : ~100 mg/mL (~438.37 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (9.12 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (9.12 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.3837 mL | 21.9183 mL | 43.8366 mL | |
| 5 mM | 0.8767 mL | 4.3837 mL | 8.7673 mL | |
| 10 mM | 0.4384 mL | 2.1918 mL | 4.3837 mL |